Boots ready to sell off prescription drug arm

BOOTS, the stores and drugs group, is prepared to sell or shut down its prescription pharmaceuticals arm in the wake of last week's Manoplax disaster, which has cost pounds 155m in wasted research and other investment.

Senior Boots managers, advised by the US management consultancy Marikon, are putting the business under the microscope and will dispose of what is sellable, and close the rest, unless they are convinced that it will generate long- term value for shareholders.

The warts-and-all examination is expected to take months, but the deadline for a decision is thought to be in time for the interim results, due in November.

The business, Boots Pharmaceuticals, employs 7,800 people, including 2,200 in the UK. It has a large research team, two sales forces supplying GPs and hospitals, and production employees in plants at Nottingham and at Cramlington in Northumberland.

Alastair Eperon, director of corporate affairs at Boots, said: 'If the process of analysis of this business demonstrates that in the long term it's not going to be value-generating for shareholders, then we have to consider those options (disposal or closure).' His comments appear to signal a significant shift from earlier in the week when Boots said it was 'totally committed' to the business.

Sir James Blyth, chief executive, has to weigh up whether to continue to devote heavy capital expenditure to research and develop new drugs, a highly risky activity at which Boots, like Fisons, has had little recent success.

A team under David Thompson, the finance director, is putting each operating business under scrutiny. An earlier examination of Sephora, its poorly performing French health and beauty business, led to its disposal last week.

Last week Boots was forced to withdraw Manoplax, its drug for congestive heart failure, just months after launching it in the UK and US. Research showed it led to more hospital admissions, and that in larger dosages it hastened death. It was a bitter blow for Boots Pharmaceuticals, which has no other prescription drugs still under patent in the UK, and none likely to reach commercial exploitation for several more years.

Boots has already paved the way for a disposal of Boots Pharmaceuticals by separating it from its two other drug businesses, Boots Healthcare International and Boots Contract Manufacturing. BHI makes products which can be sold without prescription, such as Strepsils. BCM manufactures on behalf of third parties. It is thought that these two businesses would be retained, whatever the fate of Boots Pharmaceuticals. Together the three made operating profits of about pounds 130m last year. For the first time Boots plans to split out the profits of Boots Pharmaceuticals at its interim results.

Boots Pharmaceuticals' biggest sellers are Synthroid, a treatment for thyroid deficiency, with sales of pounds 124m, and Brufen and Froben with sales of pounds 65m and pounds 40m respectively.

These brands might attract bidders among the world's pharmaceutical companies, but the shortage of blockbuster drugs in the pipeline would depress the asking price. Prescription drug companies have plunged in value this year.

A disposal of the business would threaten jobs. Buyers would be more interested in the future income streams of existing products than the business's research and sales teams and infrastructure.

Boots is due to meet City analysts tomorrow to present details of its analysis of its 11 operating businesses. Do It All, its loss-making DIY retailing joint venture with WH Smith, has already undergone the treatment. Boots believes it can succeed in the long term, despite its horrendous losses.

Robin Gilbert, analyst with Panmure Gordon, commented: 'Boots Pharmaceuticals don't have a very strong position. It's difficult to believe they once bid for Glaxo.'

Manoplax heartache, pages 6-7

(Photograph omitted)

Start your day with The Independent, sign up for daily news emails
News
people
News
Ed Miliband received a warm welcome in Chester
election 2015
Life and Style
Apple CEO Tim Cook announces the Apple Watch during an Apple special even
fashionIs the iWatch for you? Well, it depends if you want for the fitness tech, or the style
News
Astronauts could be kept asleep for days or even weeks
scienceScientists are looking for a way to keep astronauts in a sleeplike state for days or weeks
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Ashdown Group: IT Manager / Development Manager - NW London - £58k + 15% bonus

£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Ashdown Group: Training Programme Manager - City, London

£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...

Day In a Page

NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders
Heston Blumenthal to cook up a spice odyssey for British astronaut manning the International Space Station

UK's Major Tum to blast off on a spice odyssey

Nothing but the best for British astronaut as chef Heston Blumenthal cooks up his rations
John Harrison's 'longitude' clock sets new record - 300 years on

‘Longitude’ clock sets new record - 300 years on

Greenwich horologists celebrate as it keeps to within a second of real time over a 100-day test
Fears in the US of being outgunned in the vital propaganda wars by Russia, China - and even Isis - have prompted a rethink on overseas broadcasters

Let the propaganda wars begin - again

'Accurate, objective, comprehensive': that was Voice of America's creed, but now its masters want it to promote US policy, reports Rupert Cornwell
Why Japan's incredible long-distance runners will never win the London Marathon

Japan's incredible long-distance runners

Every year, Japanese long-distance runners post some of the world's fastest times – yet, come next weekend, not a single elite competitor from the country will be at the London Marathon
Why does Tom Drury remain the greatest writer you've never heard of?

Tom Drury: The quiet American

His debut was considered one of the finest novels of the past 50 years, and he is every bit the equal of his contemporaries, Jonathan Franzen, Dave Eggers and David Foster Wallace
You should judge a person by how they peel a potato

You should judge a person by how they peel a potato

Dave Hax's domestic tips are reminiscent of George Orwell's tea routine. The world might need revolution, but we like to sweat the small stuff, says DJ Taylor
Beige is back: The drab car colours of the 1970s are proving popular again

Beige to the future

Flares and flounce are back on catwalks but a revival in ’70s car paintjobs was a stack-heeled step too far – until now
Bill Granger recipes: Our chef's dishes highlight the delicate essence of fresh cheeses

Bill Granger cooks with fresh cheeses

More delicate on the palate, milder, fresh cheeses can also be kinder to the waistline
Aston Villa vs Liverpool: 'This FA Cup run has been wonderful,' says veteran Shay Given

Shay Given: 'This FA Cup run has been wonderful'

The Villa keeper has been overlooked for a long time and has unhappy memories of the national stadium – but he is savouring his chance to play at Wembley
Timeless drama of Championship race in league of its own - Michael Calvin

Michael Calvin's Last Word

Timeless drama of Championship race in league of its own